Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease

Neurology. 2018 Jan 16;90(3):144-145. doi: 10.1212/WNL.0000000000004824.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Humans
  • Immunoglobulins, Intravenous

Substances

  • Amyloid beta-Peptides
  • Immunoglobulins, Intravenous